Markers of metastatic carcinoma of breast origin

Histopathology
Allen M GownPatricia L Kandalaft

Abstract

This review summarizes the three major breast-associated markers that can be of assistance in evaluating metastatic carcinomas for which a breast primary diagnosis is entertained. These markers include gross cystic disease fluid protein-15 (GCDFP-15), mammaglobin, and GATA3. The first two are cytoplasmic markers that show comparable sensitivities for breast cancer, although relatively few of the published studies have employed the same antibodies against the target molecule, making direct comparisons challenging. GATA3 is a nuclear transcription factor that shows superior sensitivity to GCDFP-15 and mammaglobin. However, the specificity of GATA3 can pose challenges, inasmuch as carcinomas of the bladder and other sites can show significant levels of positivity. Determination of the optimal panel of antibodies employed in a given clinical setting will thus depend on the non-breast tumours included in the differential diagnosis.

References

Sep 1, 1991·The American Journal of Surgical Pathology·P E SwansonM R Wick
Apr 9, 1998·Virchows Archiv : an International Journal of Pathology·P ViacavaG Bevilacqua
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M HarveyD C Allred
May 16, 2003·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Wakako KawabataHironobu Sasano
Jul 12, 2005·Endocrine Journal·Yoshiyuki KariyaHironobu Sasano
Mar 17, 2006·Applied Immunohistochemistry & Molecular Morphology : AIMM·Sean K LauLawrence M Weiss
Dec 6, 2006·American Journal of Clinical Pathology·Rohit BhargavaDavid J Dabbs
Dec 29, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Eiichi SasakiYasushi Yatabe
Feb 13, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·David VoducTorsten Nielsen
Feb 28, 2008·The American Journal of Surgical Pathology·Joan M StriebelSamuel A Yousem
Jun 27, 2008·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Kazuya OnumaRohit Bhargava
Dec 17, 2008·Human Pathology·Vincenzo CioccaJuan P Palazzo
Jul 22, 2009·Applied Immunohistochemistry & Molecular Morphology : AIMM·Li J WangMurray B Resnick
Oct 3, 2009·Journal of Cellular Physiology·Jonathan ChouZena Werb
Oct 31, 2009·Applied Immunohistochemistry & Molecular Morphology : AIMM·Carmen Gomez-FernandezMehrdad Nadji
Feb 23, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Michael Yang, Daisuke Nonaka
Mar 30, 2010·The Breast : Official Journal of the European Society of Mastology·Shi Yun ChiaPuay Hoon Tan
Nov 17, 2010·Human Pathology·Nam K YoonLee Goodglick
Jul 23, 2011·Genes & Cancer·Rena Zheng, Gerd A Blobel
Mar 15, 2012·Lancet·Nicholas Pavlidis, George Pentheroudakis
Apr 26, 2012·The American Journal of Surgical Pathology·Stephanie BarakMarkku Miettinen
Apr 10, 2014·American Journal of Clinical Pathology·Haiyan LiuFan Lin
Jul 30, 2014·BMC Cancer·Silvia Darb-EsfahaniSibylle Loibl
Sep 5, 2014·The American Journal of Surgical Pathology·Natalie BanetRussell Vang
Mar 11, 2015·Histopathology·Jelena MirkovicMichelle S Hirsch
Jul 3, 2015·The American Journal of Surgical Pathology·Brooke E HowittMichelle S Hirsch
Aug 15, 2015·The American Journal of Surgical Pathology·Georgios DeftereosUma Krishnamurti
Sep 12, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Carol E DeSantisAhmedin Jemal

❮ Previous
Next ❯

Citations

Apr 6, 2016·Case Reports in Obstetrics and Gynecology·Vuthinun AchariyapotaMongkol Benjapibal
Nov 7, 2017·Virchows Archiv : an International Journal of Pathology·Rola H AliDiana N Ionescu
Sep 11, 2019·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·T BonachoJ Liberal
Jun 20, 2020·Proteomics. Clinical Applications·Chen ChenHans Neubauer
Nov 24, 2017·International Journal of Surgical Pathology·Alexander FeldmanJennifer Gordetsky
Aug 25, 2018·Case Reports in Oncological Medicine·Frank S FanYi-Fen Wang
Oct 5, 2020·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Di AiQingqing Ding
Jan 12, 2020·Pathology, Research and Practice·Muhammad S Qazi, Stephanie M McGregor
Nov 20, 2020·International Journal of General Medicine·Xue WanYulan Peng
Aug 25, 2020·Annals of Diagnostic Pathology·Ameer HamzaCharles C Guo
Apr 17, 2021·Nature Reviews. Disease Primers·Diamantis I TsilimigrasTimothy M Pawlik
Aug 20, 2021·Surgical Case Reports·Yoko OmiTakahiro Okamoto
Feb 12, 2021·Archives of Pathology & Laboratory Medicine·Marissa J WhiteAshley Cimino-Mathews
Jul 30, 2021·The American Journal of Surgical Pathology·Shaolei LuYihong Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.